Skip to main content
OpenTrials
Completed

NCT Number: NCT02420808

An Epidemiological Cohort Study of Acute Coronary Syndromes in The Greek Population. The PHAETHON Study

A nationwide registry of patients with acute coronary disease to evaluate epidemiological patient characteristics, medical management, implementation of invasive strategy, patient outcome and impact on quality of life in Greece.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronary Artery Disease Angina Pectoris Angina, Unstable Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Chest Pain Coronary Disease Heart Diseases Infarction Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Neurologic Manifestations Non-ST Elevated Myocardial Infarction Pain Pathologic Processes Pathological Conditions, Signs and Symptoms ST Elevation Myocardial Infarction Signs and Symptoms Vascular Diseases

Age range

25 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

General Hospital of Chalkida

Chalcis, Greece

About this study

A nationwide registry of patients with acute coronary disease to evaluate epidemiological patient characteristics, medical management, implementation of invasive strategy, patient outcome and impact on quality of life in Greece.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Informed Consent
  • > 25 years
  • Admission in hospital within 24 hours from beginning of symptoms of transfer from antother hospital within 24 hours from beginning of symptoms.
  • Acute Coronary Syndrom

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. Evaluation of patients with Acute Coronary Syndromes.

    Time frame: 6 months

    Assessment of the epidemiological characteristics of patients who were hospitalized with a diagnosis of ACS. Evaluation of the therapeutic strategy and its outcome.

Secondary outcomes

  1. Estimation of the percentage of patients.

    Time frame: Baseline

    Estimation of the percentage of patients who were hospitalized with STEMI, NSTEMI and unstable angina.

  2. Description of the methods of patients' evacuation.

    Time frame: Baseline

    Description of the methods of patients' evacuation from the scene of the incident to the receiving hospital where was processed the treatment for ACS.

  3. Estimation of the interval until the arrival in the hospital.

    Time frame: Baseline

    Estimation of the duration from the onset of pain until the arrival in the receiving hospital at various locations.

  4. Evaluation of the blood test analysis during hospitalization.

    Time frame: Baseline

    Evaluation of hematological, biochemical parameters and myocardial necrosis markers during hospitalization.

  5. Description of the administered medication.

    Time frame: Baseline - 6 months

    Description of the pharmaceutical treatment administered during hospitalization and monitoring period.

  6. Evaluation of the male patients with erectile dysfunction.

    Time frame: Baseline - 6 months

    Estimation of the percentage of the male patients with erectile dysfuction based to a predesigned questionnaire and investigation of the possible association with the treatment's outcome.

Sponsors and collaborators

Lead sponsor

Hellenic Cardiovascular Research Society

Other

Registry information

Acronym: PHAETHON

Important dates

Study start
2012
Primary completion
2013
Study completion
2014
First posted
Apr 20, 2015
Registry last updated
Mar 3, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.